Literature DB >> 11521195

The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.

A Morrione1, M Navarro, G Romano, M Dews, K Reiss, B Valentinis, B Belletti, R Baserga.   

Abstract

H19-7/IGF-IR cells are rat hippocampal cells expressing a human IGF-I receptor, which differentiate to a neuronal phenotype when stimulated by IGF-I at 39 degrees C. H19-7/IGF-IR cells have low levels of expression of insulin receptor substrate-l (IRS-1), a major substrate of the IGF-IR. IGF-I induces serine-phosphorylation and down-regulation of the endogenous IRS-1 upon differentiation of H19-7/IGF-IR cells. The profound influence of IRS-1 on differentiation of H19-7/IGF-IR cells was confirmed by transfecting these cells with a plasmid expressing mouse IRS-1. Over-expression of wild type IRS-1 in H19-7/IGF-IR cells abolishes IGF-I-induced differentiation at 39 degrees C. A mutant of IRS-1 lacking the PTB domain loses the ability to inhibit the differentiation program. H19-7/IGF-IR/IRS-1 cells at 39 degrees C show a stronger and prolonged activation of Akt, when compared to H19-7/IGF-IR cells. The role of Akt in the inhibition of the differentiation program was confirmed by using the inhibitor of Class I PI3 kinases LY29400, which restores IGF-I-induced differentiation of H19-7/IGF-IR/IRS-1 cells. H19-7/IGF-IR/IRS-1 cells show a strong reduction in MAP kinases signaling, which is related to the superactivation of Akt. This was confirmed by expressing in H19-7/IGF-IR cells a constitutively active Akt, which inhibited MAP kinases activation in these cells. These experiments confirm the importance of MAPK in the mechanism of IGF-I-mediated differentiation of H19-7/IGF-IR cells

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521195     DOI: 10.1038/sj.onc.1204649

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  IGF1 regulates RUNX1 expression via IRS1/2: Implications for antler chondrocyte differentiation.

Authors:  Zhan-Qing Yang; Hong-Liang Zhang; Cui-Cui Duan; Shuang Geng; Kai Wang; Hai-Fan Yu; Zhan-Peng Yue; Bin Guo
Journal:  Cell Cycle       Date:  2017-01-05       Impact factor: 4.534

2.  Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins.

Authors:  Bo Feng; Peng Hu; Shu-Jun Lu; Rong Wang; Yi-Feng Du
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Insulin Receptor Substrate-1 Activation Mediated p53 Downregulation Protects Against Hypoxic-Ischemia in the Neonatal Brain.

Authors:  Yi-Fang Tu; Si-Tse Jiang; Yen-Hung Chow; Chao-Ching Huang; Chien-Jung Ho; Ya-Ping Chou
Journal:  Mol Neurobiol       Date:  2015-06-26       Impact factor: 5.590

4.  Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.

Authors:  Marco Prisco; Arianna Maiorana; Clara Guerzoni; George Calin; Bruno Calabretta; Renate Voit; Ingrid Grummt; Renato Baserga
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  Proepithelin is an autocrine growth factor for bladder cancer.

Authors:  Francesca Lovat; Alessandro Bitto; Shi-Qiong Xu; Matteo Fassan; Silvia Goldoni; David Metalli; Vera Wubah; Peter McCue; Ginette Serrero; Leonard G Gomella; Raffaele Baffa; Renato V Iozzo; Andrea Morrione
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

6.  Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.

Authors:  Marco Genua; Shi-Qiong Xu; Simone Buraschi; Stephen C Peiper; Leonard G Gomella; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

7.  Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.

Authors:  Simone Buraschi; Shi-Qiong Xu; Manuela Stefanello; Igor Moskalev; Alaide Morcavallo; Marco Genua; Ryuta Tanimoto; Ruth Birbe; Stephen C Peiper; Leonard G Gomella; Antonino Belfiore; Peter C Black; Renato V Iozzo; Andrea Morrione
Journal:  Oncotarget       Date:  2016-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.